Researchers ID anti-inflammatory proteins as therapy targets for nasal and sinus problem

Johns Hopkins Medicine researchers have identified a protein—DMBT1S8—as a target for potential therapies to treat inflammation in the nasal and sinus cavities. The researchers’ findings were published March 20, 2021, in the journal Glycobiology. Nasal and sinus inflammation—known medically as chronic rhinosinusitis—is one of the most common chronic illnesses in the United States, according to the U.S. Centers for Disease […]
» Read more